Custom tombstone marking Roche’s acquisition of Constitution Medical Inc. Headquartered in Boston, CMI is a developer of laboratory products
These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Custom tombstone marking Roche’s acquisition of Constitution Medical Inc. Headquartered in Boston, CMI is a developer of laboratory products
Lab beaker-themed deal toy commemorating a private placement of shares in Oasmia Pharmaceutical. Based in Uppsala, Sweden, Oasmia specializes in drug development in human and veterinary oncology.
Lucite deal toy celebrating the acquisition of health insurance claims processor MultiPlan by Starr Investment Holdings. Both Starr and Multiplan are headquartered in New York City.
Lucite tombstone commemorating the IPO of French medical technology company Implanet on the NYSE Euronext regulated market in Paris. The company, which specializes in vertebral and knee-surgery implants, is headquartered in Bordeaux.
Americus/Biogen Custom Lucite commemorating research agreement between Amicus Therapeutics and Biogen. The collaboration centers on a preclinical program for Parkinson’s Disease.
Lucite deal toy commemorating the public offering on the Tel Aviv Stock Exchange of CollPlant. CollPlant manufactures medical devices for tissue repair, is headquartered in Ness-Ziona, Israel.
Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
